医沛生医疗器械技术咨询（北京）有限公司_公司详情_供应商

制药在线首页

公司概况
成立年份： 1984
总资产(USD)：不愿意公开
员工总人数： 500以上
主要竞争优势：品牌，国际认证/标准，经验丰富的研发人员，生产能力，产品线丰富，合同定制，接受买家的规格要求，良好的信誉，优质服务
其他竞争优势： -质量体系
专利与版权：知识产权 — 融入每一个产品在 Ypsomed，我们凭借丰富的装置经验，对注射装置专利态势有着深刻的了解。我们的设计工程师与内部和外部专利专家紧密合作，确保所有的装置解决方案均具备可靠的知识产权保护且未侵犯第三方专利。此外，我们还持有若干同族专利，包括主要国家针对笔型注射器和自助注射器技术以及注射笔针头所授予的专利及相关专利申请。通过维护知识资本，我们为客户提供所需的定制解决方案，确保从竞争对手中脱颖而出。除了积极保护创新，我们还不断监测专利环境，因此我们对特定的自助注射装置专利态势拥有一个全面、深入的了解。在 Ypsomed，我们凭借众多的同族专利，包括主要国家针对创新注射装置技术而授予的专利以及相关专利申请，为定制开发和量身定制的知识产权解决方案奠定了独特基础。

业务概况
业务类型：制造商
年销售额(USD)：不愿意公开
主要销售市场：北美洲，中/南美洲，西欧，东欧，大洋洲，亚洲，中东，非洲
主要产品类别：包材及给药装置
所有产品：注射系统：一次性注射笔，可重复使用注射笔，自动注射器，固定剂量注射笔，双腔卡式瓶注射笔
外销比重：
内销比重：
主要客户：通化东宝；万邦

其它信息
合同定制：
付款条款：

公司详情

Ypsomed is a Swiss based developer and manufacturer of self-injection devices with more than 30 years of experience and numerous high precision and high quality devices on the global market. Ypsomed provides a complete range of technologies and services for reliable and user-friendly self-injection systems for injectables such as insulin, GLP-1, hGH and mAbs. Our customers are pharmaceutical and biotechnology companies worldwide that develop, manufacture and market medications for self-injection.

Ypsomed 总部设于瑞士，是自我注射器械行业公认的先驱，拥有超过 30 年的经验。 Ypsomed为可靠的人性化自我用药注射系统提供全方位的技术和服务。从技术开发、设计到制造和包装，Ypsomed 为注射药物产品的安全性和市场成功做出了至关重要的贡献。我们的客户是开发、生产和销售注射剂型的制药和生物技术公司。

里程碑

Over 30 years Disetronic / Ypsomed

1984 Foundation Disetronic Medical Systems

1985 First micro insulin pump H-Tron MRS-1 (Hoechst)；Programming unit H-Tron MRS (Hoechst)；Reusable injection pen D-Pen

1986 Injection pen OptiPen I (Insulin / Hoechst)

1987 Commissioning tool manufacturing

1988 Foundation subsidiary Germany

1989 Continuous blood pressure monitor；Commissioning injection moulding plant；Dual-chamber injection pen (hGH / Kabi)

1990 First electronic injection pen OptiPen (Insulin / Hoechst)

1991 H-TRON V100 insulin pump；OptiPen Metall (Insulin / Hoechst)；OptiPen 2 Starlet (Insulin / Hoechst)；Profilomat (continuous blood pressure meter / Roche)

1992 Building of class D clean room；Needle for OptiPen

1993 ISO certification

1994 Panomat syringe pump 5 ml & 10 ml

1995 Founding of a subsidiary company in the Netherlands；Reusable electronic injection pen (hGH / Eli Lilly)；Reusable electronic injection pen (hGH / Pharmacia)

1996 Founding of a subsidiary company in France；“Click-on” pen needle Penfine；Disetronic listed on Swiss Stock Exchange；Reco Pen (Epo / Boehringer Ingelheim)

1997 Founding of a subsidiary company in Sweden；OptiPen Pro (Insulin / Hoechst)

1998 Dahedi insulin pump；Reusable Disetronic-Pen；HumatroPen (hGH / Eli Lilly)；Roferon-Pen (α-Interferon / Roche)

1999 Commissioning production site Lochbach, Burgdorf；Disposable pen OptiSet (Insulin / Hoechst Marion-Roussell)

2000 D-Tron insulin pump – type A cartridges (Insulin / Eli Lilly)；Disetronic infusion set；Genotropin Pen 2 (hGH / Pharmacia & Upjohn)；Disetronic Multifuse (ambulatory infusion pump)

2001 Distribution of BGM System FreeStyle™ (TheraSense / Europe)

2002 D-Tron plus insulin pump；Nutropin AQ Pen (hGH/Genentech)；Starlet Pen (Insulin/Dongbao, China)

2003 Sale of Disetronic's insulin pump business to Roche；Foundation diabetics mail order business DiaExpert in Germany；Company renamed Ypsomed；Genotropin Pen (hGH/Pharmacia & Upjohn)

2004 Ypsomed listed on Swiss Stock Exchange；Disposable Gonal-f Pen (FSH/Merck-Serono)

2005 Semi-disposable Pen OptiClik (Insulin/Sanofi-Aventis)；Acquisition of new industrial site in Solothurn, Switzerland

2006 Manufacturer certification in Japan；Preotact Pen (PTH / Nycomed)；Dongbao electronic pen (Insulin / Dongbao, China)

2007 Acquisition of various diabetes sales organisations in Germany；Reusable HumatroPen 3 (hGH / Eli Lilly)

2008 Founding of a subsidiary company in India；New logistics and manufacturing site in Burgdorf, Switzerland；Disposable SymlinPen (Symlin / Amylin Pharmaceuticals)；YpsoPen (Insulin / Polfa Tarchomin, Poland)

2009 Launch of mylife Diabetescare umbrella brand；10% share in Bionime Corp., in Taiwan；Solostar pen components (Insulin/Sanofi)；red dot design award for ServoPen platform；mylife Pura blood glucose monitoring system in Europe

2010 Foundation subsidiary United Kingdom；mylife OmniPod insulin patch pump in Europe (Insulin)；Gansulin Pen (Insulin/Dongbao, China)；Disposable Genotropin GoQuick (hGH/Pfizer)；Second generation mylife "click-on" pen needle；BiomatikPen (Insulin/Pharmstandard, Russia)；mylife "click-on" safety pen needle；Good Design Award for mylife Clickfine AutoProtect

2011 Infusion set for Luer-based insulin pumps；Launch of umbrella brand YDS Delivery Systems；mylife SafetyLancets；Omnifill (Insulin/B.Braun)；Acquisition infusion business Orbit from ICU Medical, US

2012 Foundation subsidiary Austria；mylife DailyDose；mylife OmniPod 2nd Generation；AnsuPen (Insulin/Square, Bangladesh)；ConviPen (Insulin/Incepta, Bangladesh)

2013 mylife Clickfine 4 mm / 32G Nadel；Lupisulin Pen (Insulin/Lupin, India)；mylife Penfine Classic (Schraubnadel)；mylife Unio und mylife AutoLance；mylife Orbit Reservoir；Foundation subsidiary Italy；YpsoMate autoinjector (clinical trials)；reddot design award for mylife Unio；Sulin Pen (Insulin/Dongbao, China)；Biosulin Pen (Insulin/MJ Biopharm, India)

2014 Albiglutide LyoTwist (GLP-1 / GlaxoSmithKline, US)；BiomatikPen 2 (Insulin / Pharmstandard, Russia)；Bydureon Pen (GLP-1 / Astra Zeneca, UK)；Palatin Autoinjector (BMT / Palatin Technologies, US)

2015 mylife Clickfine DiamondTip pen needle；mylife Clickfine AutoProtect 5mm / 31G；Lupisulin Pen (Insulin/Lupin, India)；PolhuminPen (Insulin/Polfa Tarohomin, Poland)；id Pen (Insulin/Indar, Ukraine)

2016 Launch of mylife™ YpsoPump® in several European countries

2017 Ypsomed decides to launch mylife™ YpsoPump® in further countries in Europe and abroad

2018 Further expansion of direct sales to more than 20 subsidiaries

联系我们